BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 12511857)

  • 21. Rhinosinusitis: what is the desired outcome?
    Merenstein D
    Am Fam Physician; 2004 Nov; 70(9):1642, 1645. PubMed ID: 15554480
    [No Abstract]   [Full Text] [Related]  

  • 22. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Sinus and Allergy Health Partnership.
    Otolaryngol Head Neck Surg; 2000 Jul; 123(1 Pt 2):5-31. PubMed ID: 10887346
    [No Abstract]   [Full Text] [Related]  

  • 23. High prevalence of antibiotic resistance in isolates from the middle meatus of children and adults with acute rhinosinusitis.
    Huang WH; Fang SY
    Am J Rhinol; 2004; 18(6):387-91. PubMed ID: 15706987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Executive summary. Sinus and Allergy Health Partnership.
    Otolaryngol Head Neck Surg; 2000 Jul; 123(1 Pt 2):1-4. PubMed ID: 10887345
    [No Abstract]   [Full Text] [Related]  

  • 25. Bacterial infection and antibiotic treatment in chronic rhinosinusitis.
    Brook I
    Clin Allergy Immunol; 2007; 20():147-62. PubMed ID: 17534050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An approach to the diagnosis and management of acute bacterial rhinosinusitis.
    Zacharek MA; Malani PN; Benninger MS
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):271-8. PubMed ID: 15918784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J; Profant M; Kostrica R; Waskin H
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy/safety of amoxicillin/clavulanate in adults with bacterial rhinosinusitis.
    Anon JB; Berkowitz E; Breton J; Twynholm M
    Am J Otolaryngol; 2006; 27(4):248-54. PubMed ID: 16798401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological treatments for rhinosinusitis.
    Taghizadeh F; Hadley JA; Osguthorpe JD
    Expert Opin Pharmacother; 2002 Mar; 3(3):305-13. PubMed ID: 11866681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiology of recurrent acute rhinosinusitis.
    Brook I; Frazier EH
    Laryngoscope; 2004 Jan; 114(1):129-31. PubMed ID: 14710008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of acute bacterial rhinosinusitis caused by antimicrobial-resistant Streptococcus pneumoniae.
    Anon JB
    Am J Med; 2004 Aug; 117 Suppl 3A():23S-28S. PubMed ID: 15360094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetically enhanced amoxicillin/clavulanate (2,000/125 mg) in acute bacterial rhinosinusitis caused by Streptococcus pneumoniae, including penicillin-resistant strains.
    Anon JB; Ferguson B; Twynholm M; Wynne B; Berkowitz E; Poole MD
    Ear Nose Throat J; 2006 Aug; 85(8):500, 502, 504 passim. PubMed ID: 16999056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns.
    File TM; Benninger MS; Jacobs MR
    Clin Lab Med; 2004 Jun; 24(2):531-51. PubMed ID: 15177852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute bacterial rhinosinusitis in adults: part I. Evaluation.
    Scheid DC; Hamm RM
    Am Fam Physician; 2004 Nov; 70(9):1685-92. PubMed ID: 15554486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of acute bacterial rhinosinusitis.
    Conrad DA; Jenson HB
    Curr Opin Pediatr; 2002 Feb; 14(1):86-90. PubMed ID: 11880740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amoxicillin-clavulante as the gold standard empirical therapy of acute bacteria rhinosinusitis.
    Brook I
    Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1367-9. PubMed ID: 23253313
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute community-acquired bacterial sinusitis: the value of antimicrobial treatment and the natural history.
    Gwaltney JM; Wiesinger BA; Patrie JT
    Clin Infect Dis; 2004 Jan; 38(2):227-33. PubMed ID: 14699455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute bacterial rhinosinusitis: current approaches to diagnosis and antibacterial therapy in out patient setting (recommendations of American Academy of otolaryngology, head and neck surgery, American Association of rhinologists, American Academy of ENT allergic diseases, 2000, Clinical consultative Committee for sinusitis in children and adults, 2000, American Academy of pediatrics, 2001, Center of disease and control, USA, 2001)].
    Tarasov AA; Kamanin EI; Kriukov AI; Strachunskiĭ LS
    Vestn Otorinolaringol; 2003; (2):46-54. PubMed ID: 12958867
    [No Abstract]   [Full Text] [Related]  

  • 39. [Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis].
    Klossek JM
    Rev Laryngol Otol Rhinol (Bord); 2007; 128(3):187-92. PubMed ID: 18323331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease severity in acute bacterial rhinosinusitis is greater in patients infected with Streptococcus pneumoniae than in those infected with Haemophilus influenzae.
    Benninger M; Brook I; Farrell DJ
    Otolaryngol Head Neck Surg; 2006 Oct; 135(4):523-8. PubMed ID: 17011411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.